- Home
- SMC vs ERAS Comparison
SMC vs ERAS Comparison
Compare SMC & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMC
- ERAS
- Stock Information
- Founded
- SMC 2009
- ERAS 2018
- Country
- SMC United States
- ERAS United States
- Employees
- SMC N/A
- ERAS N/A
- Industry
- SMC
- ERAS Biotechnology: Pharmaceutical Preparations
- Sector
- SMC
- ERAS Health Care
- Exchange
- SMC NYSE
- ERAS Nasdaq
- Market Cap
- SMC 322.4M
- ERAS 348.4M
- IPO Year
- SMC 2012
- ERAS 2021
- Fundamental
- Price
- SMC $24.69
- ERAS $1.38
- Analyst Decision
- SMC
- ERAS Strong Buy
- Analyst Count
- SMC 0
- ERAS 6
- Target Price
- SMC N/A
- ERAS $4.83
- AVG Volume (30 Days)
- SMC 78.4K
- ERAS 1.7M
- Earning Date
- SMC 08-07-2025
- ERAS 08-11-2025
- Dividend Yield
- SMC N/A
- ERAS N/A
- EPS Growth
- SMC N/A
- ERAS N/A
- EPS
- SMC N/A
- ERAS N/A
- Revenue
- SMC $444,383,000.00
- ERAS N/A
- Revenue This Year
- SMC N/A
- ERAS N/A
- Revenue Next Year
- SMC N/A
- ERAS N/A
- P/E Ratio
- SMC N/A
- ERAS N/A
- Revenue Growth
- SMC N/A
- ERAS N/A
- 52 Week Low
- SMC $24.39
- ERAS $1.01
- 52 Week High
- SMC $45.89
- ERAS $3.45
- Technical
- Relative Strength Index (RSI)
- SMC 35.94
- ERAS 47.63
- Support Level
- SMC $24.46
- ERAS $1.31
- Resistance Level
- SMC $26.50
- ERAS $1.49
- Average True Range (ATR)
- SMC 0.88
- ERAS 0.12
- MACD
- SMC 0.04
- ERAS -0.02
- Stochastic Oscillator
- SMC 11.45
- ERAS 18.37
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.